Efficacy and Safety of Dianicline Versus Placebo as an Aid to Smoking Cessation

An International 7-Week, Double-Blind, Placebo-Controlled, 2-Parallel Group Study to Assess the Efficacy of Dianicline 40 mg BID as an Aid to Smoking Cessation in Cigarette Smokers

The primary objective is to demonstrate the efficacy of dianicline as an aid to smoking cessation in cigarette smokers. The main secondary objectives are: to assess the craving for cigarettes, nicotine withdrawal symptoms and the safety of dianicline.

Inclusion Criteria:

• Outpatients over the legal age smoking at least 10 cigarettes per day for at least 2 months

Exclusion Criteria:

• Insufficient level of motivation
• Another participant in the household
• Patients with current psychotic disorder or major depressive disorder

The investigator will evaluate whether there are other reasons why a patient may not participate.